LEERINK PHARMACEUTICAL INVESTMENTS
DEAD

Serial Number

87055159

Owner

LEERINK PARTNERS LLC

Attorney

Cynthia Johnson Walden

First Use Date

Jun 24, 2014

Filing Date

May 31, 2016

Add to watchlist:

No watchlists yet
View on USPTO

LEERINK PHARMACEUTICAL INVESTMENTS Trademark

Serial Number: 87055159

LEERINK PHARMACEUTICAL INVESTMENTS is a trademark filed by LEERINK PARTNERS LLC on May 31, 2016. The trademark is classified under Class 36 (Insurance & Financial). The application is currently no longer active.

Owner Contact Info

LEERINK PARTNERS LLC (7 trademarks)

ONE FEDERAL STREET
BOSTON, MA 02110

Entity Type: 16

Trademark Details

Filing Date

May 31, 2016

Registration Date

Not Registered

First Use Anywhere

June 24, 2014

First Use in Commerce

June 24, 2014

Goods & Services

financial asset management; investment advisory and fund management services, including investment consultation; operation, administration, capital raising and management of private equity funds, venture capital funds, hedge funds, capital investment funds and collective investment vehicles

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jun 13, 2018 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jun 13, 2018 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 10, 2017 GNFN
FINAL REFUSAL E-MAILED
Nov 10, 2017 GNFR
FINAL REFUSAL WRITTEN
Nov 10, 2017 CNFR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 24, 2017 GNRN
NON-FINAL ACTION E-MAILED
Mar 24, 2017 GNRT
NON-FINAL ACTION WRITTEN
Mar 24, 2017 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 4, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 3, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 3, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 6, 2016 GNRN
NON-FINAL ACTION E-MAILED
Sep 6, 2016 GNRT
NON-FINAL ACTION WRITTEN
Sep 6, 2016 CNRT
ASSIGNED TO EXAMINER
Aug 29, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 7, 2016 NWOS
NEW APPLICATION ENTERED
Jun 3, 2016 NWAP